True Star

True Star is a leading Chinese Contract Research Organization (CRO) and Site Management Organization (SMO) that provides comprehensive clinical trial services to the global pharmaceutical and biotechnology industries. Founded in 2005 and headquartered in Beijing, the company specializes in clinical trial management, regulatory affairs, medical writing, and site coordination. In 2014, True Star was acquired by Hangzhou Tigermed Consulting, one of China's largest clinical CROs, for approximately 500 million RMB. This acquisition integrated True Star's extensive network of clinical sites and its expertise in site management into Tigermed's broader service offerings. Today, True Star plays a pivotal role in facilitating clinical research in China, ensuring that trials meet both domestic NMPA and international regulatory standards across various therapeutic areas, including oncology and cardiovascular disease.